Publication: Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum
Issued Date
2005-11-01
Resource Type
ISSN
00199567
Other identifier(s)
2-s2.0-27744520417
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Infection and Immunity. Vol.73, No.11 (2005), 7375-7380
Suggested Citation
Takeshi Arakawa, Ai Komesu, Hitoshi Otsuki, Jetsumon Sattabongkot, Rachanee Udomsangpetch, Yasunobu Matsumoto, Naotoshi Tsuji, Yimin Wu, Motomi Torii, Takafumi Tsuboi Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum. Infection and Immunity. Vol.73, No.11 (2005), 7375-7380. doi:10.1128/IAI.73.11.7375-7380.2005 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/16544
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum
Other Contributor(s)
University of the Ryukyus
Ehime University, School of Medicine
Armed Forces Research Institute of Medical Sciences, Thailand
Mahidol University
Graduate School of Agricultural and Life Sciences The University of Tokyo
Central Region Agricultural Research Center NARO
National Institute of Allergy and Infectious Diseases
Ehime University
Ehime University, School of Medicine
Armed Forces Research Institute of Medical Sciences, Thailand
Mahidol University
Graduate School of Agricultural and Life Sciences The University of Tokyo
Central Region Agricultural Research Center NARO
National Institute of Allergy and Infectious Diseases
Ehime University
Abstract
Malaria transmission-blocking vaccines based on antigens expressed in sexual stages of the parasites are considered one promising strategy for malaria control. To investigate the feasibility of developing noninvasive mucosal transmission-blocking vaccines against Plasmodium falciparum, intranasal immunization experiments with Pichia pastoris-expressed recombinant Pfs25 proteins were conducted. Mice intranasally immunized with the Pfs25 proteins in the presence of a potent mucosal adjuvant cholera toxin induced robust systemic as well as mucosal antibodies. All mouse immunoglobulin G (IgG) subclasses except IgG3 were found in serum at comparable levels, suggesting that the immunization induced mixed Th1 and Th2 responses. Consistent with the expression patterns of the Pfs25 proteins in the parasites, the induced immune sera specifically recognized ookinetes but not gametocytes. In addition, the immune sera recognized Pfs25 proteins with the native conformation but not the denatured forms, indicating that mucosal immunization induced biologically active antibodies capable of recognizing conformational epitopes of native Pfs25 proteins. Feeding Anopheles dirus mosquitoes with a mixture of the mouse immune sera and gametocytemic blood derived from patients infected with P. falciparum resulted in complete interference with oocyst development in mosquito midguts. The observed transmission-blocking activities were strongly correlated with specific serum antibody titers. Our results demonstrated for the first time that a P. falciparum transmission-blocking vaccine candidate is effective against field-isolated parasites and may justify the investigation of noninvasive mucosal vaccination regimens for control of malaria, a prototypical mucosa-unrelated mosquito-borne parasitic disease. Copyright © 2005, American Society for Microbiology. All Rights Reserved.